clofibrate has been researched along with gw 9578 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, PJ; Henke, BR; Sternbach, DD; Willson, TM | 1 |
Berthelot, P; Chavatte, P; Desreumaux, P; Farce, A; Furman, C; Lebègue, N; Millet, R; Pirat, C; Renault, N; Speca, S; Yous, S | 1 |
Berge, RK; Derudas, B; Fruchart, JC; Gervois, P; Guerre-Millo, M; Herbert, JM; Madsen, L; Poulain, P; Raspé, E; Staels, B; Willson, TM; Winegar, DA | 1 |
2 review(s) available for clofibrate and gw 9578
Article | Year |
---|---|
The PPARs: from orphan receptors to drug discovery.
Topics: Animals; Diabetes Mellitus; Drug Design; Humans; Hyperlipidemias; Hypertension; Inflammation; Ligands; Models, Molecular; Neoplasms; Nuclear Proteins; Obesity; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |
Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators.
Topics: Animals; Humans; Ligands; Metabolic Syndrome; Models, Molecular; Molecular Targeted Therapy; Peroxisome Proliferator-Activated Receptors | 2012 |
1 other study(ies) available for clofibrate and gw 9578
Article | Year |
---|---|
Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity.
Topics: Adipose Tissue; Animals; Butyrates; Clofibrate; Fenofibrate; Hypolipidemic Agents; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Phenylurea Compounds; Rats; Rats, Zucker; Receptors, Cytoplasmic and Nuclear; Transcription Factors | 2000 |